Wnt/β-catenin signaling pathway inhibits the proliferation and apoptosis of U87 glioma cells via different mechanisms

Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma

(2016) Robert A. Fenstermaker et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms

(2016) Kathryn M. Kingsmore et al.   Integrative Biology

Estrogen receptor α enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner

(2015) Peng Cao et al.   BMC CANCER

HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways

(2015) Ran Duan et al.   Oncotarget

GSK-3β regulates tumor growth and angiogenesis in human glioma cells

(2015) Peng Zhao et al.   Oncotarget

Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance

(2015) Anil Belur Nagaraj et al.   Oncotarget

Targeting TGF-β signaling in cancer

(2013) Lior H Katz et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway

(2013) Qifeng Li et al.   Journal of Translational Medicine

The Pathobiology of Collagens in Glioma

(2013) Leo S. Payne et al.   MOLECULAR CANCER RESEARCH

TCTP promotes glioma cell proliferation in vitro and in vivo via enhanced  -catenin/TCF-4 transcription

(2013) X. Gu et al.   NEURO-ONCOLOGY

miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase

(2013) Kun Wang et al.   NEURO-ONCOLOGY

Laminin alpha 2 enables glioblastoma stem cell growth

(2012) Justin D. Lathia et al.   ANNALS OF NEUROLOGY

Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression

(2012) Marco Reis et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Wnt Signaling in Vertebrate Neural Development and Function

(2012) Kimberly A. Mulligan et al.   Journal of Neuroimmune Pharmacology

FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis

(2011) Nu Zhang et al.   CANCER CELL

Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas

(2011) Yuji Guo et al.   HISTOPATHOLOGY

False Discovery Rate Control With Groups

(2010) James X. Hu et al.   JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION

Structure–activity relationship studies of small-molecule inhibitors of Wnt response

(2009) Jianming Lu et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Targeting the transforming growth factor-β signaling pathway in human cancer

(2009) Nagathihalli S Nagaraj et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]

(2009) D Gareth R Evans   GENETICS IN MEDICINE

Modulation of hyaluronan production by CD44 positive glioma cells

(2009) Marzenna Wiranowska et al.   INTERNATIONAL JOURNAL OF CANCER

A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells

(2009) K.-H. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth

(2008) P Pu et al.   CANCER GENE THERAPY

Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3

(2008) Michal O. Nowicki et al.   NEURO-ONCOLOGY

The Wnt signaling pathway: Aging gracefully as a protectionist?

(2008) Kenneth Maiese et al.   PHARMACOLOGY & THERAPEUTICS